The role of osteoclast differentiation and function in skeletal homeostasis

Journal of Biochemistry

Volumn 159, Issue 1, 2016, Pages 1-8

  Ikeda, Kyoji ^a   Takeshita, Sunao ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

glutaminolysis; glycolysis; iron; mitochondria; PGC 1

Indexed keywords

BIOCHEMISTRY; BIOENERGY; BIOSYNTHESIS; CELL CONTACT; CELL DIFFERENTIATION; CELL PROLIFERATION; HOMEOSTASIS; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; REVIEW; SKELETAL HOMEOSTASIS; ANIMAL; BONE; BONE DEVELOPMENT; BONE MARROW CELL; CYTOLOGY; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; HOMEOSTASIS; HUMANS; MICE; NFATC TRANSCRIPTION FACTORS; OSTEOBLASTS; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84966269445     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvv112     Document Type: Review

References (44)

1. Erlebacher, A., Filvaroff, E.H., Gitelman, S.E., and Derynck, R. (1995) Toward a molecular understanding of skeletal development. Cell 80, 371-378
2. Kronenberg, H.M. (2003) Developmental regulation of the growth plate. Nature 423, 332-336
3. Zaidi, M. (2007) Skeletal remodeling in health and disease. Nat. Med. 13, 791-801
4. Teitelbaum, S.L. (2000) Bone resorption by osteoclasts. Science (New York, N.Y.) 289, 1504-1508
5. Teitelbaum, S.L. and Ross, F.P. (2003) Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638-649
6. Fumoto, T., Takeshita, S., Ito, M., and Ikeda, K. (2014) Physiological functions of osteoblast lineage and T cellderived RANKL in bone homeostasis. J. Bone Miner.Res. 29, 830-842
7. Takeshita, S., Fumoto, T., Naoe, Y., and Ikeda, K. (2014) Age-related marrow adipogenesis is linked to increased expression of RANKL. J. Biol. Chem. 289, 16699-16710
8. Xiong, J., Onal, M., Jilka, R.L., Weinstein, R.S., Manolagas, S.C., and O'Brien, C.A. (2011) Matrixembedded cells control osteoclast formation. Nat. Med. 17, 1235-1241
9. Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-Hora, M., Feng, J.Q., Bonewald, L.F., Kodama, T., Wutz, A., Wagner, E.F., Penninger, J.M., and Takayanagi, H. (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 17, 1231-1234
10. Takayanagi, H. (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. 7, 292-304
11. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M.T., and Martin, T.J. (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345-357
12. Boyle, W.J., Simonet, W.S., and Lacey, D.L. (2003) Osteoclast differentiation and activation. Nature 423, 337-342
13. Martin, T.J. (2014) Coupling factors: how many candidates can there be? J. Bone Miner. Res. 29, 1519-1521
14. Buttitta, L.A., and Edgar, B.A. (2007) Mechanisms controlling cell cycle exit upon terminal differentiation. Curr. Opin. Cell Biol. 19, 697-704
15. Sakaue-Sawano, A., Kurokawa, H., Morimura, T., Hanyu, A., Hama, H., Osawa, H., Kashiwagi, S., Fukami, K., Miyata, T., Miyoshi, H., Imamura, T., Ogawa, M., Masai, H., and Miyawaki, A. (2008) Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132, 487-498
16. Motiur Rahman, M., Takeshita, S., Matsuoka, K., Kaneko, K., Naoe, Y., Sakaue-Sawano, A., Miyawaki, A., and Ikeda, K. (2015) Proliferation-coupled osteoclast differentiation by RANKL: cell density as a determinant of osteoclast formation. Bone 81, 392-399
17. Tanaka, S., Takahashi, N., Udagawa, N., Tamura, T., Akatsu, T., Stanley, E.R., Kurokawa, T., and Suda, T. (1993) Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J. Clin. Invest. 91, 257-263
18. Mizoguchi, T., Muto, A., Udagawa, N., Arai, A., Yamashita, T., Hosoya, A., Ninomiya, T., Nakamura, H., Yamamoto, Y., Kinugawa, S., Nakamura, M., Nakamichi, Y., Kobayashi, Y., Nagasawa, S., Oda, K., Tanaka, H., Tagaya, M., Penninger, J.M., Ito, M., and Takahashi, N. (2009) Identification of cell cycle-arrested quiescent osteoclast precursors in vivo. J. Cell Biol. 184, 541-554
19. Ishii, K.A., Fumoto, T., Iwai, K., Takeshita, S., Ito, M., Shimohata, N., Aburatani, H., Taketani, S., Lelliott, C.J., Vidal-Puig, A., and Ikeda, K. (2009) Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat. Med. 15, 259-266
20. Indo, Y., Takeshita, S., Ishii, K.A., Hoshii, T., Aburatani, H., Hirao, A., and Ikeda, K. (2013) Metabolic regulation of osteoclast differentiation and function. J. Bone Miner. Res. 28, 2392-2399
21. Miyauchi, Y., Sato, Y., Kobayashi, T., Yoshida, S., Mori, T., Kanagawa, H., Katsuyama, E., Fujie, A., Hao, W., Miyamoto, K., Tando, T., Morioka, H., Matsumoto, M., Chambon, P., Johnson, R.S., Kato, S., Toyama, Y., and Miyamoto, T. (2013) HIF1alpha is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis. Proc. Natl. Acad. Sci. USA. 110, 16568-16573
22. Morimoto, R., Uehara, S., Yatsushiro, S., Juge, N., Hua, Z., Senoh, S., Echigo, N., Hayashi, M., Mizoguchi, T., Ninomiya, T., Udagawa, N., Omote, H., Yamamoto, A., Edwards, R.H., and Moriyama, Y. (2006) Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J. 25, 4175-4186
23. Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W.B., Fedorov, O., Morse, E.M., Keates, T., Hickman, T.T., Felletar, I., Philpott, M., Munro, S., McKeown, M.R., Wang, Y., Christie, A.L., West, N., Cameron, M.J., Schwartz, B., Heightman, T.D., La Thangue, N., French, C.A., Wiest, O., Kung, A.L., Knapp, S., and Bradner, J.E. (2010) Selective inhibition of BET bromodomains. Nature 468, 1067-1073
24. Delmore, J.E., Issa, G.C., Lemieux, M.E., Rahl, P.B., Shi, J., Jacobs, H.M., Kastritis, E., Gilpatrick, T., Paranal, R.M., Qi, J., Chesi, M., Schinzel, A.C., McKeown, M.R., Heffernan, T.P., Vakoc, C.R., Bergsagel, P.L., Ghobrial, I.M., Richardson, P.G., Young, R.A., Hahn, W.C., Anderson, K.C., Kung, A.L., Bradner, J.E., and Mitsiades, C.S. (2011) BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904-917
25. Park-Min, K.H., Lim, E., Lee, M.J., Park, S.H., Giannopoulou, E., Yarilina, A., van der Meulen, M., Zhao, B., Smithers, N., Witherington, J., Lee, K., Tak, P.P., Prinjha, R.K., and Ivashkiv, L.B. (2014) Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation. Nat. Commun. 5, 5418
26. Warburg, O. (1956) On respiratory impairment in cancer cells. Science 124, 269-270
27. DeBerardinis, R.J., Lum, J.J., Hatzivassiliou, G., and Thompson, C.B. (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7, 11-20
28. Murray, P.J., Rathmell, J., and Pearce, E. (2015) SnapShot: Immunometabolism. Cell Metab. 22, 190-190 e191
29. Tang, Y.,Wu, X., Lei,W., Pang,L., Wan, C., Shi,Z., Zhao, L., Nagy, T.R., Peng, X., Hu, J., Feng, X., Van Hul, W., Wan, M., and Cao, X. (2009) TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat. Med. 15, 757-765
30. Xian, L., Wu, X., Pang, L., Lou, M., Rosen, C.J., Qiu, T., Crane, J., Frassica, F., Zhang, L., Rodriguez, J.P., Xiaofeng, J., Shoshana, Y., Shouhong, X., Argiris, E., Mei, W., and Xu, C. (2012) Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat. Med. 18, 1095-1101
31. Ryu, J., Kim, H.J., Chang, E.J., Huang, H., Banno, Y., and Kim, H.H. (2006) Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclastosteoblast coupling. EMBO J. 25, 5840-5851
32. Pederson, L., Ruan, M., Westendorf, J.J., Khosla, S., and Oursler, M.J. (2008) Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc. Natl. Acad. Sci. USA. 105, 20764-20769
33. Rahman, M.M., Matsuoka, K., Takeshita, S., and Ikeda, K. (2015) Secretion of PDGF isoforms during osteoclastogenesis and its modulation by anti-osteoclast drugs. Biochem. Biophys. Res. Commun. 462, 159-164
34. Matsuoka, K., Park, K.A., Ito, M., Ikeda, K., and Takeshita, S. (2014) Osteoclast-derived complement component 3a stimulates osteoblast differentiation. J. Bone Miner. Res. 29, 1522-1530
35. Takeshita, S., Fumoto, T., Matsuoka, K., Park, K.A., Aburatani, H., Kato, S., Ito, M., and Ikeda, K. (2013) Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation. J. Clin. Invest. 123, 3914-3924
36. Xie,H., Cui,Z.,Wang, L.,Xia,Z., Hu,Y., Xian,L., Li,C., Xie, L., Crane, J., Wan, M., Zhen, G., Bian, Q., Yu, B., Chang, W., Qiu, T., Pickarski, M., Duong le, T., Windle, J.J., Luo, X., Liao, E., and Cao, X. (2014) PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat. Med. 20, 1270-1278
37. Andrae, J., Gallini, R., and Betsholtz, C. (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 22, 1276-1312
38. Kusumbe, A.P., Ramasamy, S.K., and Adams, R.H. (2014) Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature. 507, 323-328
39. Ramasamy, S.K., Kusumbe, A.P., Wang, L., and Adams, R.H. (2014) Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature 507, 376-380
40. Pyagay, P., Heroult, M., Wang, Q., Lehnert, W., Belden, J., Liaw, L., Friesel, R.E., and Lindner, V. (2005) Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration. Circul. Res. 96, 261-268
41. Kimura, H., Kwan, K.M., Zhang, Z., Deng, J.M., Darnay, B.G., Behringer, R.R., Nakamura, T., de Crombrugghe, B., and Akiyama, H. (2008) Cthrc1 is a positive regulator of osteoblastic bone formation. PLoS One 3, e3174
42. Yamamoto, S., Nishimura, O., Misaki, K., Nishita, M., Minami, Y., Yonemura, S., Tarui, H., and Sasaki, H. (2008) Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex. Dev. Cell. 15, 23-36
43. Baron, R., and Kneissel, M. (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat. Med. 19, 179-192
44. Duong le, T. (2012) Therapeutic inhibition of cathepsin K-reducing bone resorption while maintaining bone formation. BoneKEy Rep. 1, 67